
FDA confirms legal action against Ajay Devgn over Vimal Elaichi ad
The story in brief
The Maharashtra FDA is proceeding with legal action against Ajay Devgn over the Vimal Elaichi ad controversy, despite his court challenge. Commissioner Tukaram Mundhe confirmed the department will continue adjudication proceedings. The case, involving alleged surrogate advertising of a banned product, is set for a hearing on November 4.